EMN 240816 110.00C (EMN240816C110000) Stock Options, News & Quotes

0.15
+0.01+7.14%

15min DelayClose Jul 26 16:00 ET

0.15High0.13Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Moomoo AI

Feb 14 07:41

Eastman Chemical's statutory earnings may have been distorted by unusual items, suggesting that its true underlying earnings power could be less than its statutory profit. There are also 2 warning signs for Eastman Chemical that investors should be aware of.

We Think You Should Be Aware Of Some Concerning Factors In Eastman Chemical's (NYSE:EMN) Earnings

Moomoo AI

Jan 16 12:24

EPS growth and falling share price mismatch suggests a shift in market perception of the company. Recent sell-off could be a long-term growth opportunity, but investors should heed 2 warning signs for Eastman Chemical.

Shareholders in Eastman Chemical (NYSE:EMN) Are in the Red If They Invested Three Years Ago

Moomoo AI

Dec 10, 2023 07:02

A decline in earnings per share and ongoing risk to future dividends make Eastman Chemical less appealing for dividend-focused investors despite efforts to increase the dividend payout ratio.

Dividend Investors: Don't Be Too Quick To Buy Eastman Chemical Company (NYSE:EMN) For Its Upcoming Dividend

Moomoo AI

Nov 8, 2023 09:34

Despite Eastman Chemical's fair trading price, future buying opportunities may arise from the stock's volatility. The company's bright outlook, propelled by a predicted profit doubling, might lead to increased cash flow and share valuation. However, a thorough balance sheet analysis is recommended before investing.

Is Now An Opportune Moment To Examine Eastman Chemical Company (NYSE:EMN)?

Moomoo AI

Oct 30, 2023 08:34

Analyst Jeffrey Zekauskas from J.P. Morgan predicts Eastman Chemical's earnings to rebound in 2024. Poor performance in 2023 due to market challenges, but possible recovery driven by dividends and good free cash flow expected.

Eastman Chemical Upgraded to Overweight at J.P. Morgan